Related references
Note: Only part of the references are listed.Isochromosome der(17)(q10)t(15;17) in Acute Promyelocytic Leukemia Resulting in an Additional Copy of the RARA-PML Fusion Gene: Report of 4 Cases and Review of the Literature
Kalliopi N. Manola et al.
ACTA HAEMATOLOGICA (2010)
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience
Lionel Ades et al.
BLOOD (2010)
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations
Daniel Nowak et al.
BLOOD (2010)
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
Miguel A. Sanz et al.
BLOOD (2010)
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
Francesco Lo-Coco et al.
BLOOD (2010)
Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia
Letetia Jones et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations
Tadayuki Akagi et al.
BLOOD (2009)
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2009)
Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy
Daniel Nowak et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions
C. G. Mullighan et al.
LEUKEMIA (2009)
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG
E. Lengfelder et al.
LEUKEMIA (2009)
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia.
Charles G. Mullighan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Acquired copy number alterations in adult acute myeloid leukemia genomes
Matthew J. Walter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Genome-Wide Mapping of Copy Number Variations Using SNP Arrays
Daniel Nowak et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2009)
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
Javier de la Serna et al.
BLOOD (2008)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
MicroRNA expression in cytogenetically normal acute myeloid leukemia
Guido Marcucci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays
Go Yamamoto et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Cumulative incidence in competing risks data and competing risks regression analysis
Haesook T. Kim
CLINICAL CANCER RESEARCH (2007)
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy:: a multicenter study by the PETHEMA group
MA Sanz et al.
BLOOD (2004)
The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats
A Barbouti et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid:: effects in patients with newly diagnosed acute promyelocytic leukemia
E Lengfelder et al.
LEUKEMIA (2000)
Share Paper
